PRAME and cutaneous melanoma: To further confirm the specificity of the PRAME-targeting ImmTAC® molecule, we deleted the target peptide sequence (SLLQHLIGL) in a cutaneous melanoma cell line that expresses abundant PRAME peptide in the context of HLA-A*02:01 (MEL624).